Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal Lindeman

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Biorxiv : the Preprint Server for Biology|November 24, 2025
Single-cell spatial mapping reveals dynamic bone marrow microarchitectural alterations and enhances clinical diagnostics in MDSRyan Nachman, Aleksandra Kopacz, Caitlin Unkenholz, et al.
Neuro-Oncology|February 25, 2021
A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium studyJason Fangusaro, Arzu Onar-Thomas, Tina Young Poussaint, et al.
Leukemia|July 1, 2026
Spatial remodeling of bone marrow architecture defines tissue-state signatures of disease activity and therapeutic response in myelodysplastic neoplasmsRyan Nachman, Aleksandra Kopacz, Caitlin Unkenholz, et al.
Cancer Research|July 28, 2011
A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitorsTakaaki Sasaki, Jussi Koivunen, Atsuko Ogino, et al.
NPJ Precision Oncology|October 6, 2022
MatchMiner: an open-source platform for cancer precision medicineHarry Klein, Tali Mazor, Ethan Siegel, et al.
Nature Communications|November 19, 2023
Comprehensive genomic characterization of HER2-low and HER2-0 breast cancerPaolo Tarantino, Hersh Gupta, Melissa E Hughes, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
Clinicogenomic characterization of inflammatory breast cancerNolan Priedigkeit, Beth Harrison, Robert Shue, et al.
Cancer Immunology Research|May 28, 2015
Long-term Benefit of PD-L1 Blockade in Lung Cancer Associated with JAK3 ActivationEliezer M Van Allen, Hadrien G Golay, Yan Liu, et al.
JCO Precision Oncology|March 30, 2023
Clinical Targeted Next-Generation Panel Sequencing Reveals <i>MYC</i> Amplification Is a Poor Prognostic Factor in OsteosarcomaAmanda E Marinoff, Liam F Spurr, Christina Fong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2025
Clinicogenomic characterization of inflammatory breast cancerNolan Priedigkeit, Beth Harrison, Robert Shue, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Biorxiv : the Preprint Server for Biology|November 24, 2025
Single-cell spatial mapping reveals dynamic bone marrow microarchitectural alterations and enhances clinical diagnostics in MDSRyan Nachman, Aleksandra Kopacz, Caitlin Unkenholz, et al.
Neuro-Oncology|February 25, 2021
A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium studyJason Fangusaro, Arzu Onar-Thomas, Tina Young Poussaint, et al.
Leukemia|July 1, 2026
Spatial remodeling of bone marrow architecture defines tissue-state signatures of disease activity and therapeutic response in myelodysplastic neoplasmsRyan Nachman, Aleksandra Kopacz, Caitlin Unkenholz, et al.
Cancer Research|July 28, 2011
A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitorsTakaaki Sasaki, Jussi Koivunen, Atsuko Ogino, et al.
NPJ Precision Oncology|October 6, 2022
MatchMiner: an open-source platform for cancer precision medicineHarry Klein, Tali Mazor, Ethan Siegel, et al.
Nature Communications|November 19, 2023
Comprehensive genomic characterization of HER2-low and HER2-0 breast cancerPaolo Tarantino, Hersh Gupta, Melissa E Hughes, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
Clinicogenomic characterization of inflammatory breast cancerNolan Priedigkeit, Beth Harrison, Robert Shue, et al.
Cancer Immunology Research|May 28, 2015
Long-term Benefit of PD-L1 Blockade in Lung Cancer Associated with JAK3 ActivationEliezer M Van Allen, Hadrien G Golay, Yan Liu, et al.
JCO Precision Oncology|March 30, 2023
Clinical Targeted Next-Generation Panel Sequencing Reveals <i>MYC</i> Amplification Is a Poor Prognostic Factor in OsteosarcomaAmanda E Marinoff, Liam F Spurr, Christina Fong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2025
Clinicogenomic characterization of inflammatory breast cancerNolan Priedigkeit, Beth Harrison, Robert Shue, et al.
Pageof 7